Scholars Central

Research articlePublished 23 Jul 2018

New generation implantable cardiac rhythm devices allow safe radiotherapy treatments: A large single centre study

Authors: Simone Gulletta Md, Mario Matta Md, Italo Dall'oca Md, Giuseppe D'angelo Md, Lorenzo Gigli Md, Andrea Radinovic Md, Manuela Cireddu Md, Aless, Ra Marzi Md, Simone Sala Md, Nadia Di Muzio Md, Paolo Della Bella Md, Pasquale Vergara Md

Current Research: Cardiology

Volume 5 · Issue 2 · Pages 15–17

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

INTRODUCTION: Many patients requiring radiotherapy for malignancies have an already implanted cardiac rhythm device. Previous studies reported a variety of device dysfunctions related to high dose radiation. Aim of this study was to assess the impact of current optimal radiotherapy treatment guided by computed tomography on current generation implantable devices. METHODS: Consecutive patients with implanted pacemakers (PMK) and implantable cardioverter defibrillators (ICD) referred for radiotherapy treatment in any district were enrolled at our Centre and followed prospectively with device interrogation before and just after each radiotherapy cycle. A magnet was positioned on the device in patients with implanted defibrillators or pacemaker-dependency. RESULTS: Overall, 48 patients (74.8 years (9.3), 39 males (81.3)) with implantable devices underwent radiotherapy (29 pacemakers and 19 ICDs). Interval between device implant and start of radiation therapy was 2.9 (1.6) years. Radiotherapy was performed under computed tomography guidance, and a mean of 73.5 (45.0) Gy were administered with a mean of 24.8 (14.6) fractionated doses. About half of the patients underwent thoracic radiotherapy, and 9 were treated for a left thoracic malignancy ipsilateral to the implanted device. No device failures were observed at post-treatment device interrogation, nor changes in electrical parameters, inappropriate shocks, device reprogramming or memory reset. None of the patients experienced premature battery failure or other unexpected anomalous findings at the end of the radiation therapy cycle. CONCLUSION: Radiation therapy for malignancies is safe among patients with implanted current generation cardiac rhythm devices.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCurrent Research: Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Simone Gulletta Md”
  • BylineArticles whose byline prints “Mario Matta Md”
  • BylineArticles whose byline prints “Italo Dall'oca Md”
  • BylineArticles whose byline prints “Giuseppe D'angelo Md”
  • BylineArticles whose byline prints “Lorenzo Gigli Md”
  • BylineArticles whose byline prints “Andrea Radinovic Md”
  • BylineArticles whose byline prints “Manuela Cireddu Md”
  • BylineArticles whose byline prints “Aless”